MedTrace Logo

Monolaurin Ointment Versus Mupirocin Ointment

NCT06046937 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-10-17

No results posted yet for this study

Summary

Skin infection remains one of the leading causes of pediatric consults especially in developing countries like the Philippines. This common condition has not been considered a significant problem that could cause alarm as public health importance. Furthermore, due to the consideration that skin diseases are benign, not life-threatening, and low priority.

Conditions

Interventions

DRUG

Monolaurin

applied thinly twice a day

DRUG

Mupirocin ointment

applied thinly twice a day

Sponsors & Collaborators

  • Victoriano Luna Medical Center

    lead OTHER_GOV

Principal Investigators

  • Elizabeth Sanchez, MD · V. Luna Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-06-30
Completion
2023-07-15

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06046937 on ClinicalTrials.gov